Gastrointestinal stromal tumours (GIST) of the jejunum in a patient with neurofibromatosis type 1 (von Recklingshausen's disease);Gastrointestinale stromatumoren (GIST) des jejunums bei einer patientin mit neurofibromatose typ 1 (morbus von Recklinghausen)

Zeitschrift fur Gastroenterologie

Volumn 42, Issue 10, 2004, Pages 1183-1187

  Köppen, Stefan ^a   Wejda, B ^a   Dormann, A ^a   Hoffmeister, D ^a   Stolte, M ^b   Huchzermeyer, H ^a  

^a KLINIKUM MINDEN   (Germany)

^b INSTITUTE OF PATHOLOGY   (Germany)

Author keywords

Gastrointestinal stromal tumour (GIST); Neurofibromatosis; Von Recklingshausen's disease

Indexed keywords

ABDOMINAL MASS; AGED; ANEMIA; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; ENDOSCOPY; FEMALE; GASTROINTESTINAL STROMAL TUMOR; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JEJUNUM TUMOR; LAPAROTOMY; MELENA; NEUROFIBROMATOSIS;

AGED; ANEMIA; BIOPSY; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; JEJUNAL NEOPLASMS; MELENA; NEOPLASMS, MULTIPLE PRIMARY; NEUROFIBROMATOSIS 1;

EID: 8444230883     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-813587     Document Type: Article

References (35)

1. Barker D, Wright E et al. Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17. Science 1987; 236: 1100-1102
2. Von Recklinghausen K. Über die multiplen Fibrome der Haut und ihre Beziehungen zu den multiplen Neuromen. Berlin: August Hirschwald, 1882
3. Zöller MET, Rembeck B et al. Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population. Cancer 1997; 11: 2125-2131
4. Tadashi H, Yoshihiro M, Tadakazu S et al. Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade. Human Pathol 2002; 33 (6): 669-676
5. Miettinen M et al. Gastrointestinal stroma tumors: recent advances in understanding their biology. Hum Pathol 1999; 30: 1213-1220
6. Huchzermeyer H, Otto P, Seifert E et al. Gastrointestinale Beteiligung bei generalisierter Neurofibromatose. Leber Magen Darm 1973; 3 (4): 177-181
7. Marchuk DA, Saulino AM et al. cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. Genomics 1991; 11: 931-940
8. Shen MH, Harper PS, Upadhyaya M. Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet 1996; 33: 2-17
9. Rutkowski JL et al. Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1. Human Molecular Genetics 2000; 9 (7): 1059-1066
10. Artaza T, Garcia JF et al. Simultaneous Involvement of the Jejunum and the Colon by Type 1 Neurofibromatosis. Scand J Gastroenterol 1999; 34: 331-334
11. Sakaguchi N, Sano K et al. A case of von Recklingshausen's disease with bilateral pheochromocytoma, malignant peripheral nerve sheath tumors of the adrenal and gastrointestinal autonomie nerve tumors. Am J Surg Pathol 1996; 20 (7): 889-897
12. Licht JD, Weissmann LB, Antmann K. Gastrointestinal sarcomas. Semin Oncol 1988; 15: 181-188
13. Wang L, Vargas H, French SW. Cellular origin of gastrointestinal stromal tumors. Arch Pathol Lab Med 2000; 124: 1471-1475
14. Joensuu H. Treatment of Inoperable Gastrointestinal Stromal Tumor (GIST) with lmatinib (Glivec®, Gleevec©). Med Klin 2002; 97: (Suppl I): 28-30
15. Nishida T, Hirota S. Biological and clinical review of stromal tumors in the gastrointestinal tract. Histol Histopathol 2000; 15:1293-1301
16. Pidhorecky I, Cheney RT, Kraybill WG et al. Gastrointestinal stromal tumors current diagnosis, biologic behavior and management. Ann Surg Oncol 2000; 7 (9): 705-712
17. Lux ML, Rubin BP, Blase TL et al. KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors. Amer J Pathol 2000; 156: 791-795
18. Kindblom LG, Remotti HE et al. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 1998; 152: 1259-1269
19. Sircar K, Hewlett B, Riddell RH. Most gastrointestinal stromal tumors arise from interstitial cells of Cajal. Mod Pathol 1998; 11: 401A
20. Lasota J, Jasinski M, Sarlomo-Rikala M et al. Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas. Amer J Pathol 1999; 154: 53-60
21. Miettinen M, Lasota J. Gastrointestinal stromal tumors - definition, clinical, histological, immunhistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 2001 ; 438: 1-12
22. Ng N et al. Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Ann Surg 1992; 215: 68-77
23. De Matteo RP, Lewis JJ, Leung D et al. Two hundred GIST. Ann Surg 2000; 1: 51-58
24. Mylonaki M, Fritscher-Ravens A, Swain P. Wireless capsule endoscopy: a comparison with push enteroscopy in patients with gastroscopy and colonoscopy negative gastrointestinal bleeding. Gut 2003; 52 (8): 1122-1126
25. Burkill GJ, Badran M et al. Malignant gastrointestinal stromal tumor: distribution, imaging features, and pattern of metastatic spread. Radiology 2003; 226 (2): 527-532
26. Stroobants S, Goeminne J et al. ISFDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec). Eur J Cancer 2003; 39 (14): 2012-2020
27. Conlon KC, Casper ES, Brennan MF. Primary gastrointestinal sarcomas, analysis of prognostic variables. Ann Surg Oncol 1995; 2: 26-31
28. Belloni M, De Fiori E et al. Endoscopic ultrasound and computed tomography in gastric stromal tumours. Radiol Med (Torino) 2002; 103 (1-2): 65-73
29. Stelow EB, Stanley MW et al. Endoscopic ultrasound-guided fine-needle aspiration findings of gastrointestinal leiomyomas and gastrointestinal stromal tumors. Am J Clin Pathol 2003; 119 (5): 703-708
30. Wu PC, Langermann A, Ryan CW et al. Surgical treatment of gastrointestinal stromal tumors in the imatinib (STI-571) era. Surgery 2003; 134 (4): 656-656
31. Lehnert T. Gastrointestinal sarcoma (GIST), a review of surgical treatment. Ann Chir Gynaecol 1998; 87: 297-305
32. Van Oosterom AT, Judson I et al. Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal tumours: a phase 1 study. The Lancet 2001; 358: 1421-1423
33. Joensuu H, Fletcher C, Dimitrijevic S et al. Management of malignant gastrointestinal stromal tumours. Lancet Oncol 2002; 3 (11): 655-664
34. Bumming P, Andersson J, Meis-Kindblom JM et al. Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patients. Br J Cancer 2003; 89 (3): 460-464
35. Emory T, Sobin L, Lukes L et al. Prognosis of gastrointestinal smooth muscle (stromal) tumors, dependence on anatomic site. Am J Surg Pathol 1999; 23: 82-87